ResMed (RMD) | Stock Overview & Key Data
ResMed Performance Comparison
Stock Range
Today's Range
Low: $269.77
High: $277.35
on October 2, 2025
52 Week Range
Low: $199.92
High: $293.81
on April 7, 2025
on August 22, 2025
All-Time High: $301.34 on September 6, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$40.1B
EPS
9.54
P/E Ratio (TTM)
28.41
Forward P/E
26.34
P/B Ratio
6.65
PEG Ratio
0.94
Div. Yield
0.63%
ROE
25.86%
Beta
0.848
Debt to Equity
14.27
Financial Highlights
Profitability
Gross Margin
60.84%
Operating Margin
33.87%
Profit Margin
27.22%
Returns and Earnings
Return on Assets (TTM)
14.02%
Return on Equity (TTM)
25.86%
EBITDA
$1.9B
Net Income (TTM)
$1.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$35.16
Quarterly Revenue Growth (YoY)
10.20%
Quarterly Earnings Growth (YoY)
29.90%
Dividend Information
Last 12-Month Dividend
$1.59
Current Dividend Yield
0.63%
3-Year Average Dividend Yield
0.23%
3-Year Average Annual Dividend
$1.60
3-Year Total Dividends
$4.79
Ex-Dividend Date
February 13, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| ResMed RMD | 40.08B Large-cap | 3.49% | 2.08% | 8.11% | 24.05% | 21.08% | 18.23% | 24.38% | 57.07% |
| Intuitive Surgical ISRG | 157.45B Large-cap | 1.12% | -5.56% | -18.05% | -12.63% | -15.46% | -8.08% | 134.79% | 80.04% |
| Becton, Dickinson BDX | 54.91B Large-cap | 6.10% | 1.83% | 8.08% | -15.38% | -15.40% | -19.57% | -13.95% | -17.24% |
| Alcon ALC | 45.84B Large-cap | 2.55% | -4.04% | -15.89% | -18.88% | -9.99% | -22.78% | 28.31% | 21.85% |
| West Pharmaceutical WST | 19.61B Large-cap | 7.34% | 12.07% | 23.48% | 23.32% | -16.82% | -7.87% | 9.34% | -8.42% |
| Hologic HOLX | 14.94B Large-cap | 3.22% | 1.95% | 4.00% | 12.14% | -5.34% | -15.37% | 6.51% | -2.13% |
Ownership & Short Interest
Insider Ownership
0.79%
Institutional Ownership
64.78%
Shares Short
9M
Short Ratio
8.77
Short % of Shares Outstanding
6.80%
Average 10-Day Volume
841K
Average 90-Day Volume
937K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is RMD's 52-week high and low?
- In the last 52 weeks, ResMed reached a high of $293.81 (on August 22, 2025) and a low of $199.92 (on April 7, 2025).
- What is the market cap and P/E ratio for RMD?
- Curious about ResMed's size and valuation? Its market capitalization stands at 40.08B. When it comes to valuation, the P/E ratio (trailing twelve months) is 28.41, and the forward P/E (looking ahead) is 26.34.
- Does RMD pay dividends? If so, what's the yield?
- Yes, ResMed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.63%, and the company has paid an average of $1.60 per share annually over the past 3 years.
- Who are ResMed's main competitors or similar companies to consider before investing?
When looking at ResMed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG157.45B Healthcare Medical Instruments & Supplies -8.08% 134.79% Becton, Dickinson
BDX54.91B Healthcare Medical Instruments & Supplies -19.57% -13.95% Alcon
ALC45.84B Healthcare Medical Instruments & Supplies -22.78% 28.31% West Pharmaceutical
WST19.61B Healthcare Medical Instruments & Supplies -7.87% 9.34% Hologic
HOLX14.94B Healthcare Medical Instruments & Supplies -15.37% 6.51% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for ResMed Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of ResMed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.86%, the Debt to Equity ratio from the most recent quarter is 14.27, and its Gross Profit Margin stands at 60.84%.
- What is the recent revenue and earnings growth for RMD?
- Looking at ResMed's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.20%, and quarterly earnings saw a YoY growth of 29.90%.
- How much of RMD stock is held by insiders and institutions?
- Wondering who owns ResMed stock? Company insiders (like executives and directors) hold about 0.79% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 64.78%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.